Table 2.
The association between levels of LDH and neutrophil and clinicopathological characteristics in patients with ESCC.
| Characteristics | LDH (U/L) | Neutrophil (109/L) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ≦220 | >220 | χ2 /t | p | ≦4.5 | >4.5 | χ2 /t | p | ||
| Age (years) | 0.637 | 0.425 | 2.2812 | 0.131 | |||||
| ≦65y | 187 (53.9) | 111 (50.5) | 123 (49) | 175 (55.4) | |||||
| >65y | 160 (46.1) | 109 (49.5) | 128 (51) | 141 (44.6) | |||||
| Gender | 0.190 | 0.663 | 10.231 | 0.001 | |||||
| Female | 92 (26.5) | 62 (28.2) | 85 (33.9) | 69 (21.8) | |||||
| Male | 255 (73.5) | 158 (71.8) | 166 (66.1) | 247 (78.2) | |||||
| Location | 1.919 | 0.589 | 2.172 | 0.538 | |||||
| Cervical | 19 (5.5) | 18 (8.2) | 13 (5.2) | 24 (7.6) | |||||
| Upper thoracic | 79 (22.8) | 46 (20.9) | 60 (23.9) | 65 (20.6) | |||||
| Middle thoracic | 205 (59.1) | 131 (59.5) | 146 (58.2) | 190 (59.3) | |||||
| Lower thoracic | 44 (12.7) | 25 (11.4) | 32 (12.7) | 37 (12.2) | |||||
| T stage | 2.166 | 0.539 | 35.330 | < 0.001 | |||||
| T1 | 6 (1.7) | 3 (1.4) | 5 (2.0) | 4 (1.3) | |||||
| T2 | 95 (27.4) | 57 (25.9) | 90 (35.9) | 62 (19.6) | |||||
| T3 | 82 (23.6) | 64 (29.1) | 75 (29.9) | 71 (22.5) | |||||
| T4 | 164 (47.3) | 96 (43.6) | 81 (32.3) | 179 (56.6) | |||||
| N stage | 4.635 | 0.031 | 5.525 | 0.019 | |||||
| N0 | 83 (23.9) | 36 (16.4) | 64 (25.8) | 55 (28.7) | |||||
| N1 | 264 (76.1) | 184 (83.6) | 187 (74.2) | 261 (71.3) | |||||
| TNM stage | 0.004 | 0.952 | 17.822 | < 0.001 | |||||
| I+II | 146 (42.1) | 92 (19.4) | 130 (51.8) | 108 (34.2) | |||||
| III+IV | 201 (57.9) | 128 (45.2) | 121 (48.2) | 208 (65.8) | |||||
| NLR | 0.920 | 0.337 | 59.839 | < 0.001 | |||||
| ≦3.25 | 239 (68.9) | 143 (65.0) | 212 (84.5) | 170 (53.8) | |||||
| >3.25 | 108 (31.1) | 77 (35.0) | 39 (15.5) | 146 (46.2) | |||||